Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating expenses:
General and administrative (including stock-based compensation (Note 9))	$ 507,905	$ 357,341
Depreciation	75,879	184,884
Research and development (including stock-based compensation (Note 9))	134,489	66,586
Total operating expenses	718,273	608,811
Loss from operations	(718,273)	(608,811)
Other expense:
Interest expense, net	114,256	96,947
	114,256	96,947
Net loss	(832,529)	(705,758)
Net loss attributable to the noncontrolling interest	1,295	1,071
Net loss attributable to Bion	(831,234)	(704,687)
Dividends on preferred stock	(500)	(500)
Net loss applicable to Bion's common stockholders	$ (831,734)	$ (705,187)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.04)	$ (0.04)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	22,289,077	19,817,076